Trials / Completed
CompletedNCT02405598
Evaluation of Salbutamol as an Adjuvant Therapy for Pompe Disease
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- National Taiwan University Hospital · Academic / Other
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
evaluate if beta 2-adrenergic agonist can have adjuvant effect to patients with infantile-onset Pompe disease under enzyme replacement therapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Salbutamol | 1. Albuterol Syrup (1mL= Salbutamol 0.4mg, 60ml/bot) 2. VENTOLIN TABLETS 2MG (SALBUTAMOL SULPHATE) |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2015-07-01
- Completion
- 2016-06-01
- First posted
- 2015-04-01
- Last updated
- 2016-09-20
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT02405598. Inclusion in this directory is not an endorsement.